Schrödinger stock, software

Schrödinger stock falls 4.79 percent as ACV growth reaches 27 percent

Published on 09/24/2026 at 07:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Schrödinger stock stood at USD 29.23 on September 23, 2026, after Q2 revenue reached USD 58.89 million. Full-year ACV guidance is USD 218 million to USD 228 million.

Schrödinger stock,  software,  computational drug discovery,  ACV growth,  Nasdaq, Illustration mit AI erstellt.
Schrödinger stock, software, computational drug discovery, ACV growth, Nasdaq, Illustration mit AI erstellt.

Schrödinger stock fell 4.79 percent to USD 29.23 on Nasdaq on September 23, 2026, leaving the company valued at USD 2,184,086,763. The decline came as investors weighed solid second-quarter operating figures against the stock's position near its 52-week high of USD 31.59.

Q2 revenue beats expectations

Schrödinger reported Q2 2026 revenue of USD 58.89 million, up 7.5 percent from the same quarter a year earlier, according to MarketBeat. Adjusted earnings per share came in at USD 0.08 versus a consensus loss estimate of USD 0.41, producing a USD 0.49 positive difference against expectations.

The quarter also showed a sharper contribution from recurring software activity. Q2 annual contract value reached USD 29.6 million, a 27 percent year-over-year increase, while software revenue totaled USD 32.5 million.

ACV guidance sets the benchmark

Management maintained full-year 2026 ACV guidance of USD 218 million to USD 228 million, equivalent to 10 percent to 15 percent growth over 2025, according to the Q2 earnings transcript published by Yahoo Finance. The guidance gives investors a clearer operating benchmark than the quarter's one-time earnings benefit from other income.

Hosted revenue accounted for USD 15.2 million, or 47 percent of software revenue, compared with 31 percent in Q2 2025. That mix shift matters because it points to greater adoption of Schrödinger's recurring platform model, even as the company continues funding its drug discovery pipeline.

Stock remains near yearly high

The September 23 price of USD 29.23 stood 7.47 percent below the 52-week high of USD 31.59 and 167.03 percent above the 52-week low of USD 10.95. Schrödinger's Nasdaq listing and software-led business remain central to the valuation, while the 4.79 percent daily decline shows that strong operating comparisons have not removed short-term volatility.

Schrödinger stock at a glance

  • Company: Schrödinger, Inc.
  • Ticker: SDGR
  • Trading venue: Nasdaq
  • Price as of September 23, 2026: USD 29.23
  • Market capitalization: USD 2,184,086,763 as of September 23, 2026
  • 52-week range: USD 10.95-31.59 as of September 23, 2026
  • Sector / Industry: Technology / Software - Application

Disclaimer...

en | boerse | 70174174 |